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Abstract
Objective: The respiratory ratio is a dimensional construct of the respiratory subtype of panic 
disorder (PD). The respiratory subtype has been correlated with an increased sensitivity to CO2 
inhalation, positive family history of PD and low comorbidity with depression. The objective of 
our study was to determine whether the respiratory ratio is correlated with CO2-induced panic 
attacks and other clinical and demographic features. Methods: We examined 91 patients with 
PD and submitted them to a double-breath 35% CO2 challenge test. The respiratory ratio was 
calculated based on the Diagnostic Symptom Questionnaire (DSQ) scores recorded in a diary in 
the days preceding the CO2 challenge. The scores of the respiratory symptoms were summed and 
divided by the total DSQ score. Results: The respiratory ratio was correlated with CO2 sensitivity, 
DQGWKHUHZDVDQRQVWDWLVWLFDOO\VLJQLÀFDQWWUHQGWRZDUGVDFRUUHODWLRQZLWKDIDPLO\KLVWRU\RI
PD. Conclusions: The positive correlation between the respiratory ratio and the anxiety elicited 
by the CO2 inhalation indicates that the intensity of respiratory symptoms may be proportional 
to the sensitivity to carbon dioxide.
© 2013 Associação Brasileira de Psiquiatria. Published by Elsevier Editora Ltda. 
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Introduction
According to the DSM-IV,1 panic disorder (PD) is a unitary 
diagnostic category. Nevertheless, within this category, 
there are diverse clinical presentations, leading to con-
cerns that PD is not a singular diagnosis.2 As a response to 
WKHVH FRQFHUQV DOWHUQDWLYH FODVVLÀFDWLRQ VFKHPHV KDYH
been devised.2 Authors have proposed that the subtypes 
should be defined by the most prominent symptoms 
during a typical panic attack (PA), such as respiratory, 
cardiovascular, and gastrointestinal subtypes.3 Respiratory 
abnormalities, such as increased sensitivity to CO2, are as-
sociated with PD, and there may be a connection between 
the respiratory subtype of PD and these abnormalities.4,5
Klein6 proposed that spontaneous PAs occur when the 
brain’s suffocation monitor erroneously signals a lack of 
useful air, maladaptively triggering an evolved suffocation 
alarm system. Such a dysfunction would make an individual 
vulnerable to “false suffocation alarms”, namely, PAs. 
Respiratory tests have been fruitful in generating hypoth-
eses about PD,6,7 indicating that CO2 sensitivity may be 
part of a hypersensitive suffocation detector.6 PD patients 
exhibit both behaviorally and physiologically abnormal 
responses to respiratory challenge tests.8,9 The CO2 inhala-
tion increases pCO2 and reduces pH in the blood, changes 
that are also observed in the brain.10 Some regions of the 
brain that are sensitive to H+/CO2 have been implicated in 
both ventilation control and defensive behaviors, including 
panic. The increase of CO2 and H+ in the brain may activate 
these structures, inducing PAs and increasing ventilation.10 
The administration of 1 or 2 vital capacity breaths of 
a 35% CO2/65% O2 mixture to patients with PD is a brief 
but intense stimulation, accompanied by neurovegetative 
symptoms similar to real-life PA symptomatology.11,12 These 
respiratory tests induce dose-dependent anxiety and panic 
symptoms in many subjects with and without PD,10,13,14 but in 
3'SDWLHQWVWKLVUHVSRQVHLVVLJQLÀFDQWO\PRUHLQWHQVH11,12,15 
,Q DGGLWLRQ KHDOWK\ ÀUVWGHJUHH UHODWLYHV RI 3' SDWLHQWV
UHDFWVLJQLÀFDQWO\PRUHWR&22 inhalations than do healthy 
subjects without a family history of PD.16 The research on 
CO2 challenge tests strongly suggests a relationship between 
the pathophysiology of PD and some disturbance in breath-
ing control.4,11 Recent studies indicate that patients with 
the respiratory subtype of PD are more sensitive to 35% CO2 
challenge tests and hyperventilation tests than subjects 
without this subtype.17-19 Hypersensitivity to CO2 and promi-
nent respiratory symptoms might be markers for genetic 
vulnerability to respiratory PD.5,16
Briggs et al.20 GHÀQHG WKH UHVSLUDWRU\ VXEW\SHRI3'
as a distinct subgroup of PD patients with prominent 
respiratory symptoms. Respiratory subtype patients are 
more likely to have a family history of PD and exhibit low 
comorbidity with depression, longer illness duration and 
low neuroticism scores.5 These patients also exhibit higher 
scores on PD severity scales, and the improvement with 
pharmacological treatment is observed more quickly than 
in patients without this subtype.20,21&RQWURYHUVLDOÀQGLQJV
also exist regarding the respiratory subtype, such as the 
correlation with the age of onset, tobacco and alcohol use.5
A principal component analysis with PD symptoms con-
ducted by Briggs et al.20 determined that the presence of the 
fear of dying, chest pain/discomfort, shortness of breath, 
SDUHVWKHVLDVDQGIHHOLQJVRIFKRNLQJGXULQJD3$GHÀQHGD
GLVWLQFWVXEJURXSRI3'SDWLHQWV,IDWOHDVWIRXURIWKHÀYH
respiratory symptoms were present in a given patient, he 
or she was considered to have the respiratory subtype.20 
Throughout the years, many studies17-19,21-23 have been based 
RQ%ULJJV·VFODVVLÀFDWLRQEXWQRQHRIWKHVWXGLHVDGGUHVVHG
WZRLPSRUWDQWSUREOHPVWKHFODVVLÀFDWLRQGRHVQRWDFFRXQW
for the intensity of the respiratory and non-respiratory symp-
toms; and patients with many symptoms have an increased 
FKDQFHWREHFODVVLÀHGZLWKWKHUHVSLUDWRU\VXEW\SH:LWK
%ULJJV·FODVVLÀFDWLRQSDWLHQWVZLWKPDUNHGJDVWURLQWHVWLQDORU
neurologic symptoms may report mild respiratory symptoms 
DQGEHLQFRUUHFWO\FODVVLÀHGLQWKHUHVSLUDWRU\VXEW\SH2Q
the other hand, if a patient has strong feelings of choking, 
shortness of breath and chest discomfort but does not experi-
ence paresthesias and fear of dying, he will not be diagnosed 
with the respiratory subtype. A method that accounted for 
the intensity of symptoms would lead to a more reliable clas-
VLÀFDWLRQRISDWLHQWVDPSOHV&RQVLVWHQWÀQGLQJVDUHUHSRUWHG
in patients with the respiratory subtype, such as a positive 
family history and high sensitivity to CO2 challenge tests.
18,19,23 
+RZHYHU3'VWXGLHVUHSRUWFRQÁLFWLQJÀQGLQJVUHJDUGLQJWKH
age of onset and comorbidities.24 These inconsistencies may 
EHGXHWRWKHOLPLWDWLRQVRIWKH%ULJJV·FODVVLÀFDWLRQ
7KH SUHYDLOLQJ V\VWHPV RI FODVVLÀFDWLRQ RI SV\FKLDWULF
disorders assume that the categorical representation is ap-
propriate; disorders are laid out as distinct types and diag-
nosed as present or absent. However, some authors propose 
that dimensional taxonomy should be used in at least some 
conditions.25 Studies indicate that dimensional constructs 
PD\EHVXSHULRUWRFDWHJRULFDOFODVVLÀFDWLRQVEHFDXVHLQDGGL-
tion to capturing the core symptoms, dimensional constructs 
capture the subtle psychopathology of anxiety disorders.25,26 
Dimensional variation exists between and within categories, 
DQGTXDQWLWDWLYHYDULDWLRQFDQEHVLPSOLÀHGLQWRFDWHJRULFDO
distinctions,25 such as the respiratory subtype.
,QWKHFXUUHQWVWXG\ZHGHÀQHGWKHUHVSLUDWRU\UDWLRD
dimensional correlate of the respiratory subtype, as the ratio 
between the respiratory and the non-respiratory symptoms 
occurring during PA, accounting for the intensity of each 
symptom. We hypothesize that the respiratory ratio is cor-
related with high sensitivity to CO2 challenges, positive family 
history of PD and a low prevalence of major depression. 
The objective of this study was to ascertain whether the 
respiratory ratio can predict CO2-induced PAs and whether 
WKHUHVSLUDWRU\UDWLRLVFRUUHODWHGZLWKVSHFLÀFFOLQLFDODQG
GHPRJUDSKLFIHDWXUHVLQ3'SDWLHQWV7KLVVWXG\LVWKHÀUVW
attempt to build a body of evidence concerning the respira-
tory ratio.
Methods
Subjects
In the current study, a database from a previous research 
project27 was used. Patients with a diagnosis of PD with ago-
raphobia were consecutively recruited as they presented to 
the Laboratory of Panic and Respiration at the Institute of 
Psychiatry of the Universidade Federal do Rio de Janeiro, 
Rio de Janeiro, Brazil. The data collection for the original 
study lasted for approximately six months. After subjects 
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received a clinical diagnosis of PD, made by an expert 
psychiatrist, they were interviewed by a second psychia-
trist with the Structured Clinical Interview Diagnostic28 for 
DSM-IV.1 If the two clinicians disagreed on the diagnosis, 
they met to confer. If a consensus on the diagnosis could 
not be reached, the subject was not enrolled. Patients who 
met the DSM-IV criteria for current major depression, bipo-
lar disorder, obsessive-compulsive disorder, schizophrenia, 
delusional or psychotic disorders, organic brain syndrome, 
severe personality disorder, suicide risk, epilepsy, or sub-
stance abuse or dependence (during the previous year) were 
excluded. Patients with comorbid dysthymia, generalized 
anxiety disorder, or past major depression were included if 
PD was judged to be the principal diagnosis. The protocol 
was explained to the subjects, who signed a voluntary writ-
ten consent form to participate in the study. The subjects 
were informed that the procedure was not dangerous, but 
that anxiety symptoms could occur during the test. Our local 
ethics committee approved the protocol (approval number 
CAAE-0008.0.249.000-05, 14/2005), which complied with the 
principles of the Declaration of Helsinki. The inclusion criteria 
selected 18 to 55 years of age; both genders; occurrence of 
at least three PAs in the two weeks before the challenge test 
day and no use of any psychotropic drugs for at least one 
week by any subject. Exclusion criteria included unstable 
medical condition; cognitive-behavior psychotherapy during 
the study; use of any regular antipsychotic, antidepressant, 
regular benzodiazepine or non-benzodiazepine anxiolytic 
PHGLFDWLRQIRUIRXUZHHNVEHIRUHWKHXVHWKHXVHRIÁXR[-
HWLQHIRUÀYHZHHNVEHIRUHWKHWHVWRUDSRVLWLYHXULQHWHVW
for benzodiazepines or other drugs before the test. Subjects 
with a history of respiratory disease and smokers were also 
excluded. All subjects underwent a physical examination and 
laboratory examinations to ensure that they were healthy 
enough to participate in a CO2 challenge test. The patients 
had no respiratory or cardiovascular abnormalities and were 
IUHHRIFDIIHLQHLQJHVWLRQIRURQHGD\$OOVXEMHFWVÀOOHGRXW
a form with sociodemographic and clinical data, including 
age, gender, education, occupation, marital status, family 
history of PD and age of onset of PD. The family members 
were not examined.
Measures
The Subjective Units of Disturbance Scale (SUDS) is a quan-
titative evaluation method ranging from 0 (no anxiety) to 10 
(maximum anxiety).29 The Diagnostic Symptom Questionnaire 
(DSQ) is a list of 13 PA symptoms adapted from DSM-IV1 in 
which the presence and level of discomfort of each panic 
symptom experienced after the inhalations is rated on a 
0- (none) to 4-point (very severe) scale, and the total score 
ranges from 0 to 52.30 Both the SUDS and DSQ were used in 
the CO2 inhalation procedure. To avoid baseline interference 
in the quantitative assessment of the SUDS measurements, 
the percentage of maximum increase or decrease pos-
sible in the SUDS score (PMIDPSUDS) was calculated.31 The 
¨68'6ZDVFDOFXODWHGDVWKHGLIIHUHQFHEHWZHHQWKH68'6
score after the CO2 inhalation (SUDS2) and the SUDS score 
EHIRUHWKHLQKDODWLRQ68'6,IWKH¨68'6ZDVQHJDWLYH
WKH30,'368'6ZDVHTXDOWRWKH¨68'6GLYLGHGE\68'6
,IWKH¨68'6ZDVSRVLWLYHWKH30,'368'6ZDVHTXDOWRWKH
¨68'6GLYLGHGE\WKHGLIIHUHQFHEHWZHHQWKHPD[LPXP68'6 
score (10) and SUDS1.31
'XULQJWKLVÀUVWYLVLWWRRXUUHVHDUFKFHQWHUHDFKSDWLHQW
received a diary in which they recorded any PAs that oc-
curred between the screen visit and the visit for the CO2 test 
one week after. The respiratory ratio was calculated based 
on the DSQ scores of non-induced PAs registered in the diary. 
The scores of the respiratory symptoms (fear of dying, chest 
pain/discomfort, shortness of breath, paresthesias, and feel-
ings of choking) were summed and divided by the total DSQ 
score for each patient.
Procedure
Before the inhalations, all subjects were asked to relax for 
10 minutes. Respiratory frequency, pulse, and blood pressure 
were checked, and the measurements were repeated 1 and 
5 minutes after the test. Using a double-blind (patient and 
medical raters) design setup, the patients inhaled the 35% CO2 
mixture or atmospheric compressed air, randomly selected 
ZLWKDFRLQÁLSE\DQLQGHSHQGHQWVWDIIPHPEHU7KHVDPH
test procedure was repeated after 20 minutes using other 
gas (i.e., 35% CO2 or compressed air). During the test pro-
cedure, the patients exhaled as fully as possible, placed the 
inhalation mask, took a fast vital capacity breath, held their 
breath for 8 seconds, exhaled, and repeated the fast vital 
capacity breath, again holding for 8 seconds. The compliance 
with the tests was established by the three members of our 
team who attended present during the tests. Both tests were 
attended by one medical staff member who dealt with the 
patient and the gases (independent staff member) and by two 
test-blind rater psychiatrists. To measure the anxiety level 
before and after the CO2 inhalation, we asked the subjects 
to complete the SUDS. The DSQ was also completed after 
the respiratory challenge.
Based on the DSQ, a CO2LQGXFHG3$ZDVGHÀQHGDVWKH
following: (1) the presence of 4 or more DSM-IV PA symp-
toms, where either the presence or the increase in DSM-IV 
symptomatology was used for diagnosis; (2) at least one 
DSM-IV cognitive panic symptom, that is, fear of dying, los-
ing control, or going crazy; (3) the patient’s statement that 
the sensation of panic or fear after the test resembled a 
spontaneous PA; and (4) an agreement of 2 medical doctors 
blind to whether the patient was receiving CO2 or compressed 
air that the patient had a clinical PA. The SUDS scores were 
not used for diagnosing a PA. All of these criteria were used 
in the diagnosis of a PA to increase the reliability and clini-
FDOVLJQLÀFDQFH
Statistical analysis
To calculate the correlations between the respiratory ra-
tio and the other variables, the authors used the Pearson 
&RUUHODWLRQ&RHIÀFLHQWIRUFRQWLQXRXVYDULDEOHVZLWKQRUPDO
GLVWULEXWLRQVWKH6SHDUPDQ·V5DQN&RUUHODWLRQ&RHIÀFLHQW
for ordinal variables and continuous variables without normal 
distributions and the Point-Biserial Correlation (PBC) to cor-
relate continuous and dichotomous variables. The PBC is a 
VSHFLDOFDVHRIWKH3HDUVRQ&RUUHODWLRQ&RHIÀFLHQWLQZKLFK
a continuous variable is correlated with a true dichotomy. 
7KH FRUUHODWLRQ FRHIÀFLHQWVZHUH FRQVLGHUHG VPDOOZKHQ
approximately .10, medium when .30 and large when .50.32
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The patients who suffered PAs after the CO2 inhalation 
H[KLELWHG VLJQLÀFDQWO\ KLJKHU UHVSLUDWRU\ UDWLRV 7KH UH-
VSRQGHUVZHUHVLJQLÀFDQWO\PRUHOLNHO\WRH[KLELWDIDPLO\
history of PD, a lower age of onset and a higher prevalence 
of previous major depression episodes. As expected, the 
68'6 30,'368'6 DQG '64ZHUH VLJQLÀFDQWO\ KLJKHU IRU 
the responders compared to the non-responders. There were 
no differences in sex, age, education, marital status, or 
occupation between the groups (Table 2).
To determine how well the respiratory ratio could predict 
CO 2-induced Pas, the ROC curve was calculated. The area 
under the curve (AUC) was .707, and the respiratory ratio 
cutoff was .437. Using this cutoff, the sensitivity was 67.7%, 
WKHVSHFLÀFLW\ZDVWKHSRVLWLYHSUHGLFWLYHYDOXHZDV
80.8% and the negative predictive value was 48.7%.
Discussion
The respiratory ratio was correlated with CO2 sensitivity. 
$ QRQVWDWLVWLFDOO\ VLJQLÀFDQW WUHQG WRZDUGV D FRUUHODWLRQ
between the respiratory ratio and a family history of PD was 
observed. A positive family history of PD, comorbidity with 
major depression and an early age of onset were correlated 
with the response to carbon dioxide inhalation.
In the current study, prominent respiratory symptoms 
were correlated with a high sensitivity to CO2, consistent 
ZLWKWKHÀQGLQJVRISUHYLRXVVWXGLHV17,18,27 Biber and Alkin17 
observed that 35% CO2 inhalation induced PAs in 79% of 
patients with the respiratory subtype, whereas only 48% 
of patients with the non-respiratory subtype suffered PAs 
during the respiratory challenge. Valenca et al.18 observed 
that 93.7% of patients with the respiratory subtype suffered 
PAs during 35% CO2 inhalation, whereas only 43.4% of patients 
with the non-respiratory subtype suffered PAs, indicating a 
higher sensitivity to CO2 in patients with the respiratory sub-
type. In a study using a 5% CO2 rebreathing challenge,
22 more 
respiratory subtype patients than non-respiratory subtype 
patients terminated the procedure voluntarily. Respiratory 
subtype patients also exhibited a higher respiratory fre-
quency and more suffocation sensations than non-respiratory 
subtype patients.22 The intensity of respiratory symptoms in 
PD patients may be proportional to the sensitivity to CO2, 
and a slight increase in CO2 levels might be misinterpreted 
as a lack of useful air, triggering PD symptoms.
$QRWKHULQWHUHVWLQJÀQGLQJIURPWKHFXUUHQWVWXG\LVWKDWWKH 
responders exhibited a higher family prevalence of PD than 
did the non-responders. Perna et al.16 described the treat-
PHQWVHHNLQJ3'SUREDQGVWKHLUÀUVWGHJUHHUHODWLYHVDQG
the relatives of normal controls. Although relatives with a 
personal history of any mental disorder were excluded, 22% 
of those related to PD probands developed a PA after one 
inhalation of 35% CO2. Fifty-one percent of the PD probands 
but only 2% of the relatives of normal controls developed 
3$VDVZHOO7KXVKLJKULVNUHODWLYHVZHUHVLJQLÀFDQWO\OHVV
likely to develop PAs with CO2 than were ill probands.
16 In a 
VLPLODUVWXG\RIWKHÀUVWGHJUHHUHODWLYHVRI3'SDWLHQWV
exhibited PAs after one inhalation of 35% CO2, whereas only 
12% of the controls exhibited PAs.33 Bellodi et al.34 conducted 
a twin study that generated strong evidence for the role of 
genetic factors in the sensitivity to CO2 inhalation. If it could 
Responders and non-responders to the CO2 challenge 
were compared with respect to their respiratory ratio and 
demographic and clinical features. The Student’s t-test was 
used to compare the means of numeric variables between 
the two groups, and the chi-square test was used to compare 
categorical variables.
To ascertain the predictive value of the respiratory ratio, 
the ROC curve was analyzed. A respiratory ratio cutoff was 
GHÀQHGEDVHGRQWKHVPDOOHVWGLIIHUHQFHEHWZHHQWKHVHQ-
VLWLYLW\DQGVSHFLÀFLW\YDOXHV7KHSRVLWLYHSUHGLFWLYHYDOXH
and negative predictive value were calculated.
All analyses were two-tailed, and the level of statistical 
VLJQLÀFDQFHZDVVHWDW
Results
A sample of 91 patients with PD was included in the trial. A 
total of 62 patients with PD (68.1%) suffered a PA after the 
CO2 test (responders), and 29 patients with PD (31.9%) did 
not suffer a PA after the test (non-responders).
In our sample, we did not reject the normality hypothesis 
of the respiratory ratio (Kolmogorov Smirnov Z, p = .872), and 
the mean was .458 (SD = .104), indicating that the respiratory 
symptoms represented approximately 45.8% of the PD symp-
toms registered in the diary of all patients. The respiratory 
ratio exhibited moderate positive correlations with PMIDPSUDS 
and the response to CO2 inhalation. We also observed trends 
towards positive correlations with SUDS2 and family history 
and a negative correlation with education (Table 1).
The hypothesis of normality was rejected for PMIDPSUDS 
(Kolmogorov Smirnov Z, p = .003) and SUDS2 (Kolmogorov 
Smirnov Z, p < .001), and linear regression based on normality 
was not possible using these variables. Although it would have 
been possible to use a nonparametric regression, it would 
KDYHEHHQGLIÀFXOWIRUSV\FKLDWULVWVWRUHDG:HGHFLGHGQRW
to base our conclusions on linear regressions.
Table 1 Correlations of the respiratory ratio.
Variable Method Correlation strength
Gender PBC .017
Age Pearson .169
Education PBC -.183 *
Occupation PBC .138
Marital status PBC .142
Family history PBC .189 *
Age of onset Pearson -.089
MDD PBC .086
DSQ Pearson .107
SUDS1 Spearman -.095
SUDS2 Spearman .198 *
PMIDPSUDS Spearman .236
CO2PA PBC .334 **
3%&3RLQWELVHULDOFRUUHODWLRQ3HDUVRQ3HDUVRQFRUUHODWLRQFRHIÀFLHQW
6SHDUPDQ6SHDUPDQ·VUDQNFRUUHODWLRQFRHIÀFLHQW0''3UHYLRXV
major depressive disorder episodes; SUDS1: SUDS score before the CO2 
inhalation; SUDS2: SUDS score after the CO2 inhalation; PMIDPSUDS: 
Percentage of maximum increase or decrease possible in the SUDS scale; 
corresponds to the anxiety increase induced by the CO2 inhalation; CO2PA: 
CO2-induced panic attack.
* p < .1; ** p <.01.
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be established that an abnormal sensitivity to CO2 comprises 
a marker for PD, the test could be used to identify individuals 
with a relatively high risk for the onset of spontaneous PAs.
Although the current study failed to demonstrate a strong 
association between the respiratory ratio and a family history 
of PD, there is evidence in the literature of an association 
between genetics and respiratory symptoms. Studies indi-
cate that 62.1% to 71.4% of PD patients with the respiratory 
subtype have a family history of PD, whereas only 31.3% to 
37.9% of patients without the respiratory subtype have a 
ÀUVWGHJUHHUHODWLYHZLWKWKLVGLVRUGHU19,23,27 Studies of the 
genetics of PD suggest that the respiratory subtype may be an 
important biological marker, although none of these studies 
have addressed this question directly.5 In the current study, 
the correlation between the respiratory ratio and a family 
KLVWRU\RI3'GLGQRWUHDFKVWDWLVWLFDOVLJQLÀFDQFHEXWIXWXUH
studies, with larger samples, may identify this association.
The main limitations of this study were the small sample 
VL]HDQGWKHODFNRIHTXLSPHQWWRFRQÀUPWKDWWKHVXEMHFWV
inhaled full vital capacities of 35% CO2 and air during the 
experiment.
Conclusion
The positive correlation between the respiratory ratio and the 
PD symptoms elicited by the CO2 inhalation indicate that 
the intensity of respiratory symptoms may be commensurable 
with the sensitivity to carbon dioxide. The respiratory ratio 
may be a useful tool in the research of PD as a bridge con-
necting the psychopathology to the underlying neurobiology.
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Table 2 Clinical features of responders and non-responders to the CO2 inhalation.
No CO2-induced panic attack CO2-induced panic attack
n / Mean % / SD n / Mean % / SD
Total 29 31.9 62 68.1
Gender                Male 12 41.4 24 38.7
                           Female 17 58.6 38 61.3
Age 36.8 9.3 39.4 10.0
Education            Low 9 31.0 16 25.8
                           High 9 69.0 46 74.2
Ocupation            Inactive 14 48.3 26 41.9
                           Active 15 51.7 36 58.1
Married 17 58.6 41 66.1
Family history * 11 37.9 40 64.5
Age of onset ** 30.4 6.1 23.2 5.1
MDD ** 13 44.8 47 75.8
Respiratory ratio ** .407 .094 .481 .100
DSQ ** 12.8 2.2 17.7 2.8
SUDS1 3.4 2.6 2.9 1.8
SUDS2 ** 3.4 1.6 8.4 1.4
PMIDPSUDS (%) ** -6.8 33.0 77.0 19.8
MDD: Previous major depressive disorder episodes; DSQ: Diagnostic Symptom Questionnaire score; SUDS1: SUDS score before the CO2 inhalation; SUDS2: 
SUDS score after the CO2 inhalation; PMIDPSUDS: Percentage of maximum increase or decrease possible on the SUDS scale; corresponds to the anxiety 
increase induced by the CO2 inhalation.
* p< .05; ** p< .005.
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